Cliff Asness's MRNA Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 38,315 shares of Moderna, Inc. (MRNA) worth $1.91 M, representing 0.00% of the portfolio. First purchased in 2020-Q1, this long-term strategic position has been held for 24 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in MRNA, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2022, adding 847,320 shares. Largest reduction occurred in Q3 2022, reducing 690,182 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Moderna (MRNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Moderna (MRNA) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +26,305 | Add 219.03% | 38,315 | $49.90 |
| Q4 2025 | +12,010 | New Buy | 12,010 | $29.49 |
| Q2 2025 | -15,253 | Sold Out | 0 | $0.00 |
| Q1 2025 | +15,253 | New Buy | 15,253 | $27.22 |
| Q4 2024 | -3,010 | Sold Out | 0 | $0.00 |
| Q3 2024 | -2,073 | Reduce 40.78% | 3,010 | $66.82 |
| Q2 2024 | +1,232 | Add 31.99% | 5,083 | $118.75 |
| Q1 2024 | +1,294 | Add 50.61% | 3,851 | $106.56 |
| Q4 2023 | +2,557 | New Buy | 2,557 | $99.44 |
| Q3 2023 | -30,132 | Sold Out | 0 | $0.00 |
| Q2 2023 | -259,320 | Reduce 89.59% | 30,132 | $121.50 |
| Q1 2023 | -19,753 | Reduce 6.39% | 289,452 | $152.82 |
| Q4 2022 | -285,180 | Reduce 47.98% | 309,205 | $174.10 |
| Q3 2022 | -690,182 | Reduce 53.73% | 594,385 | $118.25 |
| Q2 2022 | -80,803 | Reduce 5.92% | 1.28 M | $137.55 |
| Q1 2022 | +847,320 | Add 163.56% | 1.37 M | $172.26 |
| Q4 2021 | +79,961 | Add 18.25% | 518,050 | $250.01 |
| Q3 2021 | -247,604 | Reduce 36.11% | 438,089 | $379.57 |
| Q2 2021 | -281,604 | Reduce 29.11% | 685,693 | $234.98 |
| Q1 2021 | +825,570 | Add 582.51% | 967,297 | $126.40 |
| Q4 2020 | +66,122 | Add 87.46% | 141,727 | $104.47 |
| Q3 2020 | +17,472 | Add 30.06% | 75,605 | $70.75 |
| Q2 2020 | +48,240 | Add 487.62% | 58,133 | $62.91 |
| Q1 2020 | +9,893 | New Buy | 9,893 | $29.62 |
Cliff Asness's Moderna Investment FAQs
Cliff Asness first purchased Moderna, Inc. (MRNA) in Q1 2020, acquiring 9,893 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Moderna, Inc. (MRNA) for 24 quarters since Q1 2020.
Cliff Asness's largest addition to Moderna, Inc. (MRNA) was in Q1 2022, adding 1,365,370 shares worth $235.2 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 38,315 shares of Moderna, Inc. (MRNA), valued at approximately $1.91 M.
As of the Q1 2026 filing, Moderna, Inc. (MRNA) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Moderna, Inc. (MRNA) was 1,365,370 shares, as reported at the end of Q1 2022.